86 related articles for article (PubMed ID: 34403984)
41. Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.
Zhang H; Huang N; Yang G; Lin Q; Su Y
Oncotarget; 2017 Sep; 8(38):63311-63323. PubMed ID: 28968991
[TBL] [Abstract][Full Text] [Related]
42. In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy.
Yu CY; Wang YM; Li NM; Liu GS; Yang S; Tang GT; He DX; Tan XW; Wei H
Mol Pharm; 2014 Feb; 11(2):638-44. PubMed ID: 24383625
[TBL] [Abstract][Full Text] [Related]
43. Ultrasmall hybrid protein-copper sulfide nanoparticles for targeted photoacoustic imaging of orthotopic hepatocellular carcinoma with a high signal-to-noise ratio.
Yan H; Chen J; Li Y; Bai Y; Wu Y; Sheng Z; Song L; Liu C; Zhang H
Biomater Sci; 2018 Dec; 7(1):92-103. PubMed ID: 30358774
[TBL] [Abstract][Full Text] [Related]
44. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
45. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
46. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
47. Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation.
Ma X; Hui H; Jin Y; Dong D; Liang X; Yang X; Tan K; Dai Z; Cheng Z; Tian J
Biomaterials; 2016 May; 87():46-56. PubMed ID: 26897539
[TBL] [Abstract][Full Text] [Related]
48. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy.
Li Y; Miao Y; Chen M; Chen X; Li F; Zhang X; Gan Y
Theranostics; 2020; 10(8):3722-3736. PubMed ID: 32206118
[No Abstract] [Full Text] [Related]
49. Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy.
Ye PJ; Huang C; Yang S; Gao P; Li ZP; Tang SY; Xiang Y; Liu YF; Chen YP; He DX; Yu CY
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S661-S670. PubMed ID: 30307317
[TBL] [Abstract][Full Text] [Related]
50. Enhanced targeted delivery of adenine to hepatocellular carcinoma using glycyrrhetinic acid-functionalized nanoparticles in vivo and in vitro.
Wu F; Xue H; Li X; Diao W; Jiang B; Wang W; Yu W; Bai J; Wang Y; Lian B; Feng W; Sun T; Qu M; Zhao C; Wang Y; Wu J; Gao Z
Biomed Pharmacother; 2020 Nov; 131():110682. PubMed ID: 32947204
[TBL] [Abstract][Full Text] [Related]
51. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y
Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745
[TBL] [Abstract][Full Text] [Related]
52. Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
Ganguly S; Dewanjee S; Sen R; Chattopadhyay D; Ganguly S; Gaonkar R; Debnath MC
Colloids Surf B Biointerfaces; 2021 Aug; 204():111778. PubMed ID: 33915380
[TBL] [Abstract][Full Text] [Related]
53. Small gold nanorods-loaded hybrid albumin nanoparticles with high photothermal efficacy for tumor ablation.
Seo B; Lim K; Kim SS; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2019 Jul; 179():340-351. PubMed ID: 30991214
[TBL] [Abstract][Full Text] [Related]
54. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
[TBL] [Abstract][Full Text] [Related]
55. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
[TBL] [Abstract][Full Text] [Related]
57. Enhanced cytotoxic and apoptotic potential in hepatic carcinoma cells of chitosan nanoparticles loaded with ginsenoside compound K.
Zhang J; Wang Y; Jiang Y; Liu T; Luo Y; Diao E; Cao Y; Chen L; Zhang L; Gu Q; Zhou J; Sun F; Zheng W; Liu J; Li X; Hu W
Carbohydr Polym; 2018 Oct; 198():537-545. PubMed ID: 30093032
[TBL] [Abstract][Full Text] [Related]
58. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line.
Ahmadian E; Dizaj SM; Rahimpour E; Hasanzadeh A; Eftekhari A; Hosain Zadegan H; Halajzadeh J; Ahmadian H
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():465-471. PubMed ID: 30274079
[TBL] [Abstract][Full Text] [Related]
59. Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii.
Arora D; Kumar A; Gupta P; Chashoo G; Jaglan S
Bioorg Med Chem Lett; 2017 Dec; 27(23):5126-5130. PubMed ID: 29100800
[TBL] [Abstract][Full Text] [Related]
60. Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue.
Fan Y; Yuan S; Huo M; Chaudhuri AS; Zhao M; Wu Z; Qi X
Nanomedicine; 2017 May; 13(4):1399-1410. PubMed ID: 28115251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
